Loading company…
Ramat Gan, Israel-based company, founded in 2008, that sells the PMD-200 device for real-time pain assessment in hospitals.
Medasense Biometrics Ltd., founded in 2008 in Ramat Gan, Israel, develops pain assessment technology. Its PMD-200 uses NOL (Nociception Level) AI technology to assess pain responses in real time and is sold mainly to hospitals in markets including the United States, Europe and Israel. Galit Zuckerman is CEO and founder. In September 2020 the company raised USD 18.00 mn in Series C funding from Asabys Partners and Baxter Ventures, and it has completed four funding deals in total.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in